NCT02098239View on ClinicalTrials.gov

Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

April 30, 2002

Study Completion Date

May 31, 2002

Conditions
JaundicePancreatic Cancer
Interventions
DRUG

G17DT

Sponsors
All Listed Sponsors
lead

Cancer Advances Inc.

INDUSTRY

NCT02098239 - Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. | Biotech Hunter | Biotech Hunter